A Medicinal Chemistry Perspective on Protein Tyrosine Phosphatase Nonreceptor Type 2 in Tumor Immunology
Journal of Medicinal Chemistry · 2025
DOI: 10.1021/acs.jmedchem.4c01802 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Medicinal Chemistry, 2025. Verfasst von Qi Huang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Zhongshan Institute for Drug Discovery, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Zhongshan 528400, China. Hauptthemen laut MEDLINE: Neoplasms, Protein Tyrosine Phosphatase, Non-Receptor Type 2. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 159 Literaturangaben. Gefördert von: China Postdoctoral Science Foundation, Shanghai Science and Technology Development Foundation.
Abstract (Originalsprache)
PTPN2 (protein tyrosine phosphatase nonreceptor type 2) is an important member of the protein tyrosine phosphatase (PTP) family. It plays a crucial role in dephosphorylating tyrosine-phosphorylated proteins and modulating critical signaling pathways associated with T-cell receptors, IL-2, IFNγ, and various cytokines. In recent years, the PTPN2's biological role has been clarified, particularly since its association with tumor immunology was gradually revealed in 2017, making it a star target for cancer immunotherapy. The dual inhibitor AC484, which targets both PTPN2 and PTP1B, is currently undergoing phase I clinical trials. This advancement has attracted great interest from researchers to develop new drugs based on its unique structure. This review outlines the structural modification processes of PTPN2-targeted agents, focusing primarily on inhibitors and degraders. Finally, this review endeavors to provide a comprehensive perspective on the evolving field of PTPN2-targeted drug discovery for tumor immunotherapy, offering valuable insights for future drug development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Zhongshan Institute for Drug Discovery, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Zhongshan 528400, China.
- School of Pharmacy, Fudan University, 826 Zhangheng Road, Shanghai 201203, China.
- Department of Medicinal Chemistry, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
- School of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515 Guangdong China.
- School of Pharmacy, University of Chinese Academy of Sciences, Beijing 100049, China.
- The Institutes of Integrative Medicine of Fudan University, 12 Wulumuqi Zhong Road, Shanghai 200040, China.
ORCID-Profile: Xun Sun, Mingliang Wang
Förderung
- China Postdoctoral Science Foundation
- Shanghai Science and Technology Development Foundation
Zitieren
APA
Huang, Q., Hu, L., Chen, H., Yang, B., Sun, X., & Wang, M. (2025). A Medicinal Chemistry Perspective on Protein Tyrosine Phosphatase Nonreceptor Type 2 in Tumor Immunology. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.4c01802
Vancouver
Huang Q, Hu L, Chen H, Yang B, Sun X, Wang M. A Medicinal Chemistry Perspective on Protein Tyrosine Phosphatase Nonreceptor Type 2 in Tumor Immunology. Journal of Medicinal Chemistry. 2025. doi:10.1021/acs.jmedchem.4c01802
BibTeX
@article{Huang2025,
author = {Huang, Qi and Hu, Linghao and Chen, Haowen and Yang, Bingjie and Sun, Xun and Wang, Mingliang},
title = {A Medicinal Chemistry Perspective on Protein Tyrosine Phosphatase Nonreceptor Type 2 in Tumor Immunology},
journal = {Journal of Medicinal Chemistry},
year = {2025},
doi = {10.1021/acs.jmedchem.4c01802}
}
EUVIMED